PROTEIN BINDING STUDY OF FELODIPINE USING VALIDATED LIQUID CHROMATOGRAPHIC METHOD

##article.authors##

  • Swarna Vijitha Department of Pharmaceutical Analysis, Sree Vidyanikethan College of Pharmacy, Sree Sainath Nagar, Chandragiri (Mandal), Tirupati, Chittoor (Dist), A. P.
  • P. Rajavel Department of Pharmaceutical Analysis, Sree Vidyanikethan College of Pharmacy, Sree Sainath Nagar, Chandragiri (Mandal), Tirupati, Chittoor (Dist), A. P.
  • K. Udayasree Department of Pharmaceutical Analysis, Sree Vidyanikethan College of Pharmacy, Sree Sainath Nagar, Chandragiri (Mandal), Tirupati, Chittoor (Dist), A. P.

##semicolon##

Felodipine##common.commaListSeparator## RP-HPLC##common.commaListSeparator## ICH guidelines##common.commaListSeparator## RSD

##article.abstract##

Objective: The aim of present study was to develop and validate a new simple, easy, selective, precise, accurate reverse phase high-performance liquid chromatography for the estimation of felodipine in bulk and pharmaceutical dosage form.

Methods: The separation was carried on HPLC system consisting C18 column (150 mm ×4.6 nm, 5 µm) at room temperature coupled with a phenomenixcolumn silica with flow rate 1 ml/min. The mobile phase used was methanol: acetonitrile in the ratio of 50: 50. The drug was detected using UV-visible detector at the wavelength of 230 nm and run time was 10 min.

Results: The retention time was 3.138 min. Linearity was observed in the concentration range of 5-25μg/ml. The accuracy of the method was assessed by percentage recovery studies at three different levels at 80%, 100% and 120% of its working concentration. The percentage recovery of felodipine in the developed method was found to be in the ranges of from 99.81-100.00% that indicates the good accuracy of the method. The percentage % RSD of precision was found to be less than 2%. The method was validated as per ICH guidelines. The developed method was employed in in vitro protein binding studies using semi permeable membrane and performed by plotting calibration curve (peak area vs concentration) the % drug release of felodipine was calculated.

Conclusion: The proposed method was found to be simple, precise, accurate and consistent. The validated parameters are statistically validated for linearity, precision and limit of detection, limit of quantification, robustness, ruggedness were concluded.

 

##submission.citations##

The merckindex: an encyclopedia of chemicals, drugs and biological, merck research laboratories, merck; 2001.

Tripathi KD. Essentials of medical pharmacology. 6th ed. Jaypee brothers medical publishers (p) Ltd, New Delhi; 2000. p. 181-2.

Validation of analytical procedures: text and methodology, in: international conference on harmonization (ICH), Q2A, Q2B(R); 2005.

Dhalechaitali, Joshisuhas, Shubhangi. Development and validation RP-HPLC method for analysis felodipine in bulk and pharmaceutical dosage form. Int Res J Pharm 2014;5:770-2.

Sangeetha dhanaraj, Manoj Kumar Vadlamudi. Stability indicating method for the determination of related substances in felodipine solid dosage form and in the drug substance by RP-HPLCâ€. J Bioequivalence Bioavailability 2016; 851;153-66.

Arsul VA. Analytical method development and validation of felodipine by uv and rp–hplc method. Pharm Chem 2016;6:181-5.

Nataraj KS, S Sureshkumar. Method validation and estimation of felodipine in pure and capsule dosage form by RP-HPLC. J Pharm Res 2011;4:2822-3.

Liandong, Qiaofeng Hu, Na Gao. A validated stability indicating stability HPLC method for determination of felodipine and its related substances. Int J Pharm Sci Res 2015;11:1-9.

Vaibhav M Thorat, Pawar SS, Pande VV, Arote SR, Musmade Deepak. Development and validation of UV spectrophotometric method for estimation of process related impurity in felodipine bulk and formulation. Scholars Res Library 2015;7:284-90.

Gandla, Kumaraswamy. Development and validation of stability indicating RP-HPLC method for simultaneous determination of enalapril maleate and felodipine in bulk and tablet dosage form. World J Pharm Res 2015;3:2087-100.

##submissions.published##

21-09-2017

##issue.issue##

##section.section##

Original Article(s)